Rigel Pharmaceuticals | RIGL - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Agenus USD 33.74M 468K 2026-03
Amgen USD 5.87B 1.02B 2026-03
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 75.25M 1.52M 2026-06
AstraZeneca USD 12.86B 251M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Celldex Therapeutics USD 15K 106K 2026-03
Daiichi Sankyo JPY 287.15B 152.68B 2026-03
Eli Lilly USD 16.22B 301.7M 2026-03
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Heron Therapeutics USD 29.47M 3.17M 2025-12
Intrexon USD -297K 167K 2024-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Ligand Pharmaceuticals USD 100.41M 51.96M 2026-06
MacroGenics USD 11.24M 19.87M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Pfizer USD -248M 11.29B 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Veracyte USD 108.55M 7.39M 2026-06